Octavus Consulting- Evidence-Based Consulting Services.

Call us: +91 120 428 0707

Email us: bd@octavusconsulting.com

Contact Us
Contact Us

Himanshu Sehgal

  • Home
  • Author: Himanshu Sehgal
15
Dec
No Comments

Insights Corner: Discover the latest on Antibody Drug Conjugate

Insights Details Month: Aug 25 Tags: Antibody drug Conjugate, Conference, Pre-clinical, Phase 1, Phase 2, Phase 3, US FDA, EMA, Company Profile, Product profile, Deal Analysis, Funding Analysis, Landscape, Oncology, Investment, Immuno-oncology, Global Market Size, Market Trends, Future direction, Lung Cancer, Hematological malignancies, Solid Tumor, Swot Analysis, KOL Profile, Clinical trials Let’s Work Together for […]
Continue Reading
15
Dec
No Comments

EULAR 2025 Insights Corner: Psoriatic Arthritis Highlights, Competitor Landscape & Biosimilars

Insights Details Month: July 25 Tags: Eular, Conference, Pre-clinical, Phase 1, Phase 2, Phase 3, US FDA, EMA, Company Profile, Product profile, Psoriatic Arthritis, Market Trends, Landscape, Deal Analysis, Funding Analysis, Clinical trials, Biosimilar, Europe, Clinical trials Let’s Work Together for Development Call us directly, submit a sample or email us! Business Address First Floor, […]
Continue Reading
10
Sep
No Comments

Decentralized Clinical Trials: Current & Future Scenarios

An Overview With high-paced technological advancement and incessant innovations, the healthcare sectors are transcending beyond excellence. The advent of the COVID-19 pandemic has reshaped the way clinical studies function, by availing the use of telemedicine and wearable devices. Often referred to as “direct-to-participant trials” or “virtual studies”, decentralized clinical trials mitigate the dependence on conventional-style […]
Continue Reading

Categories

Subscribe Newsletter

Sign up to receive notifications about the latest news and events from us!